|
1
|
Chen Z, Zhou H, Li S, He E, Hu J, Zhou J
and Skog S: Serological thymidine kinase 1 (STK1) indicates an
elevated risk for development of malignant tumours. Anticancer Res.
28:3897–3907. 2008.PubMed/NCBI
|
|
2
|
Huang S, Lin J, Guo N, Zhang M, Yun X, Liu
S, Zhou J, He E and Skog S: Elevated serum thymidine kinase 1
predicts risk of pre/early cancerous progression. Asian Pac J
Cancer Prev. 12:497–505. 2011.PubMed/NCBI
|
|
3
|
Sherley JL and Kelly TJ: Regulation of
human thymidine kinase during the cell cycle. J Biol Chem.
263:8350–8358. 1988.PubMed/NCBI
|
|
4
|
Kauffman MG and Kelly TJ: Cell cycle
regulation of thymidine kinase: Residues near the carboxyl terminus
are essential for the specific degradation of the enzyme at
mitosis. Mol Cell Biol. 11:2538–2546. 1991.PubMed/NCBI
|
|
5
|
He Q, Zhang P, Li Z, Li H, Wang X, Zou S,
Fornander T and Skog S: Concentration of thymidine kinase 1 in
serum (S-TK1) is a more sensitive proliferation marker in human
solid tumors than its activity. Oncol Rep. 14:1013–1019.
2005.PubMed/NCBI
|
|
6
|
Welin M, Kosinska U, Mikkelsen NE, Carnrot
C, Zhu C, Wang L, Eriksson S, Munch-Petersen B and Eklund H:
Structures of thymidine kinase 1 of human and mycoplasmic origin.
Proc Natl Acad Sci USA. 101:17970–17975. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He Q, Zou L, Zhang PA, Liu JX, Skog S and
Fornander T: The clinical significance of thymidine kinase 1
measurement in serum of breast cancer patients using anti-TK1
antibody. J Biol Marker. 15:139–146. 2000.
|
|
8
|
Wu CJ, Yang R, Zhou J, Bao S, Zou L, Zhang
P, Mao Y, Wu J and He Q: Production and characterisation of a novel
chicken IgY antibody raised against C-terminal peptide from human
thymidine kinase 1. J Immuno Methods. 277:157–169. 2003. View Article : Google Scholar
|
|
9
|
He Q, Fornander T, Johansson H, Johansson
U, Hu GZ, Rutqvist LE and Skog S: Thymidine kinase 1 in serum
predicts increased risk of distant or loco-regional recurrence
following surgery in patients with early breast cancer. Anticancer
Res. 26:4753–4759. 2006.PubMed/NCBI
|
|
10
|
Aufderklamm S, Todenhöfer T, Gakis G,
Kruck S, Hennenlotter J, Stenzl A and Schwentner C: Thymidine
kinase and cancer monitoring. Cancer Lett. 316:6–10. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou J, He E and Skog S: The proliferation
marker thymidine kinase 1 in clinical use. Mol Clin Oncol. 1:18–28.
2013.PubMed/NCBI
|
|
12
|
Xu XH, Zhang YM, Shu XH, Shan LH, Wang ZW,
Zhou YL, Wen HK, He F, He E and Skog S: Serum thymidine kinase 1
reflects the progression of pre-malignant and malignant tumors
during therapy. Mol Med Rep. 1:705–712. 2008.PubMed/NCBI
|
|
13
|
Chen ZH, Huang SQ, Wang Y, Yang AZ, Wen J,
Xu XH, Chen Y, Chen QB, Wang YH, He E, et al: Serological thymidine
kinase 1 is a biomarker for early detection of tumours-a health
screening study on 35,365 people, using a sensitive
chemiluminescent dot blot assay. Sensors(Basel). 11:11064–11680.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan H, Sun Y, Zan Q, Xu M, Li Y, Zhou J,
He E, Eriksson S, Wen W and Skog S: Thymidine kinase 1 expression
in atypical ductal hyperplasia significantly differs from usual
ductal hyperplasia and ductal carcinoma in situ: A useful tool in
tumour therapy management. Mol Med Reports. 2:923–929. 2009.
|
|
15
|
Ang YK, Mirnalini K and Zalilah MS: A
workplace email-linked website intervention for modifying
cancer-related dietary and lifestyle risk factors: Rationale,
design and baseline findings. Malays J Nutr. 19:37–51.
2013.PubMed/NCBI
|
|
16
|
Sulaiman S, Shahril MR, Wafa SW,
Shaharudin SH and Hussin SN: Dietary carbohydrate, fiber and sugar
and risk of breast cancer according to menopausal status in
malaysia. Asian Pac J Cancer Prev. 15:5959–5964. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Berman JJ and Moore GW: Part I, Limitation
of Current Approaches to Cancer Treatment; Part II, Precancer
Pathology and Biology; Part III, Eradication of Cancer By Treatment
of PrecancerPrecancer: The Beginning and the End of Cancer. Jones
and Bartlett Publishers; Sudbury, MA, USA: pp. 1–113. 2010
|
|
18
|
Pandey S and Chandravati: Breast screening
in north India: A cost-effective cancer prevention strategy. Asian
Pac J Cancer Prev. 14:853–857. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cigna, . Tumor markers for cancer.
http://cignaforhcp.cigna.com/public/content/pdf/coveragePolicies/medical/mm_0172_coveragepositioncriteria_tumor_markers_for_diagnosis_mgmt_cancer.pdfAccessed
on. January 1–2015
|
|
20
|
Underwood JCE: Classification of
tumoursGeneral and Systematic Pathology. Elsevier Ltd.; pp.
227–229. pp. 240–235. pp. 374–473. pp. 4972004
|
